Institutional Ownership Ngm Biopharmaceuticals Inc (NGM)
This table provides information about the institutional ownership of Ngm Biopharmaceuticals Inc (NGM). We have compiled data on the 5 institutions that hold shares in the stock, with a total of 2.6 Million shares, which have been reported (via 13F filing form) to have a value of $0.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Ponoi Ii Management, LLC
San Francisco, CA |
Nov 14, 2022 Q3 2022 |
1,298,908
shares
|
$0
44.41% of portfolio
|
Q4 2020
New holding
|
|
|
Ponoi Management, LLC
San Francisco, CA |
Nov 14, 2022 Q3 2022 |
1,298,908
shares
|
$0
23.2% of portfolio
|
Q4 2020
New holding
|
|
|
Cutler Group LP
|
Apr 19, 2024 Q1 2024 |
3,100
shares
|
$0
0.0% of portfolio
|
Q1 2023
Added 47.62%
|
|
|
Exane Derivatives
|
Jul 12, 2022 Q2 2022 |
12
shares
|
$0
0.0% of portfolio
|
Q2 2022
Reduced 99.48%
|